Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 2
2007 1
2009 5
2010 2
2011 3
2013 1
2016 1
2023 2
2024 2
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan.
Fabi A, Rossi A, Caputo R, Pisegna S, Scagnoli S, Pantano F, D'Auria G, Fedele P, Fabbri A, Vernieri C, Palleschi M, Carbognin L, Ferretti G, Di Monte E, Paris I, Pavese F, Garrone O, Franco A, De Laurentiis M, Franceschini G, Scambia G, Giannarelli D, Masetti R, Botticelli A. Fabi A, et al. Among authors: di monte e. NPJ Precis Oncol. 2025 Jan 22;9(1):22. doi: 10.1038/s41698-025-00801-3. NPJ Precis Oncol. 2025. PMID: 39843642 Free PMC article.
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy.
Mastrantoni L, Garufi G, Giordano G, Maliziola N, Di Monte E, Arcuri G, Frescura V, Rotondi A, Orlandi A, Carbognin L, Palazzo A, Miglietta F, Pontolillo L, Fabi A, Gerratana L, Pannunzio S, Paris I, Pilotto S, Marazzi F, Franco A, Franceschini G, Dieci MV, Mazzeo R, Puglisi F, Guarneri V, Milella M, Scambia G, Giannarelli D, Tortora G, Bria E. Mastrantoni L, et al. Among authors: di monte e. NPJ Breast Cancer. 2025 Feb 5;11(1):11. doi: 10.1038/s41523-025-00727-w. NPJ Breast Cancer. 2025. PMID: 39910103 Free PMC article.
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry.
Iaffaldano P, Lucisano G, Guerra T, Patti F, Cocco E, De Luca G, Brescia Morra V, Pozzilli C, Zaffaroni M, Ferraro D, Gasperini C, Salemi G, Bergamaschi R, Lus G, Inglese M, Romano S, Bellantonio P, Di Monte E, Maniscalco GT, Conte A, Lugaresi A, Vianello M, Torri Clerici VLA, Di Sapio A, Pesci I, Granella F, Totaro R, Marfia GA, Danni MC, Cavalla P, Valentino P, Aguglia U, Montepietra S, Ferraro E, Protti A, Spitaleri D, Avolio C, De Riz M, Maimone D, Cavaletti G, Gazzola P, Tedeschi G, Sessa M, Rovaris M, Di Palma F, Gatto M, Cargnelutti D, De Robertis F, Logullo FO, Rini A, Meucci G, Ardito B, Banfi P, Nasuelli D, Paolicelli D, Rocca MA, Portaccio E, Chisari CG, Fenu G, Onofrj M, Carotenuto A, Ruggieri S, Tortorella C, Ragonese P, Nica M, Amato MP, Filippi M, Trojano M; Italian MS Register. Iaffaldano P, et al. Among authors: di monte e. J Neurol. 2024 Mar;271(3):1150-1159. doi: 10.1007/s00415-023-12137-8. Epub 2023 Dec 22. J Neurol. 2024. PMID: 38135850
Italian Multiple Sclerosis Database Network.
Trojano M, Paolicelli D, Lepore V, Fuiani A, Di Monte E, Pellegrini F, Russo P, Livrea P, Comi G; Italian MSDN Group. Trojano M, et al. Among authors: di monte e. Neurol Sci. 2006 Sep;27 Suppl 5:S358-61. doi: 10.1007/s10072-006-0694-8. Neurol Sci. 2006. PMID: 16998720
Activity and Efficacy of Neoadjuvant Chemotherapy in Luminal-HER2 Negative Early Breast Cancer According to HER2 Score (Low vs. Score 0): A Retrospective Study.
Garufi G, Mastrantoni L, Maliziola N, Di Monte E, Arcuri G, Frescura V, Rotondi A, Fabi A, Paris I, Marazzi F, Franco A, Franceschini G, Palazzo A, Orlandi A, Scambia G, Tortora G, Carbognin L, Bria E. Garufi G, et al. Among authors: di monte e. Clin Breast Cancer. 2025 Jul;25(5):431-443.e5. doi: 10.1016/j.clbc.2025.02.016. Epub 2025 Mar 5. Clin Breast Cancer. 2025. PMID: 40155250 Free article.
Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials.
Mastrantoni L, Garufi G, Di Monte E, Maliziola N, Pasqualoni M, Pontolillo L, Pannunzio S, Cannizzaro MC, Di Bello A, Fabi A, Palazzo A, Tortora G, Bria E, Orlandi A. Mastrantoni L, et al. Among authors: di monte e. Ther Adv Med Oncol. 2023 May 29;15:17588359231173180. doi: 10.1177/17588359231173180. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37284523 Free PMC article.
Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study.
Riccio P, Rossano R, Larocca M, Trotta V, Mennella I, Vitaglione P, Ettorre M, Graverini A, De Santis A, Di Monte E, Coniglio MG. Riccio P, et al. Among authors: di monte e. Exp Biol Med (Maywood). 2016 Mar;241(6):620-35. doi: 10.1177/1535370215618462. Epub 2016 Jan 18. Exp Biol Med (Maywood). 2016. PMID: 26785711 Free PMC article.
Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica.
Tortorella C, Ruggieri M, Di Monte E, Ceci E, Iaffaldano P, Direnzo V, Mastrapasqua M, Frigeri A, Amato MP, Hakiki B, Ghezzi A, Lugaresi A, De Luca G, Patti F, D'Amico E, Sola P, Simone AM, Svelto M, Livrea P, Trojano M. Tortorella C, et al. Among authors: di monte e. J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1355-9. doi: 10.1136/jnnp.2011.241836. Epub 2011 May 27. J Neurol Neurosurg Psychiatry. 2011. PMID: 21622936
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.
Radue EW, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Rudick RA, Lublin FD, Weinstock-Guttman B, Wynn DR, Fisher E, Papadopoulou A, Lynn F, Panzara MA, Sandrock AW; SENTINEL Investigators. Radue EW, et al. J Neurol Sci. 2010 May 15;292(1-2):28-35. doi: 10.1016/j.jns.2010.02.012. Epub 2010 Mar 16. J Neurol Sci. 2010. PMID: 20236661 Clinical Trial.
24 results